Biocon Ltd. (BIOCON)
Market Closed
5 Dec, 10:00
XNSE XNSE Primary MSE ₹
392. 05
+3.7
+0.95%
₹
397.02B Market Cap
- P/E Ratio
2% Div Yield
4,217,316 Volume
- Eps
₹ 388.35
Previous Close Day Range
386.3 394
Year Range
291 424.95
Want to track BIOCON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 51 days
Summary
BIOCON closed Friday higher at ₹392.05, an increase of 0.95% from Thursday's close, completing a monthly increase of 0.71% or ₹2.75. Over the past 12 months, BIOCON stock gained 6.85%.
BIOCON pays dividends to its shareholders, with the most recent payment made on Sep 05, 2025. The next estimated payment will be in In 8 months on Sep 05, 2026 for a total of ₹0.5.
The last earnings report, released on Nov 11, 2025, missed the consensus estimates by -0.25%. On average, the company has fell short of earnings expectations by -0.34%, based on the last three reports. The next scheduled earnings report is due on Jan 28, 2026.
Biocon Ltd. has completed 1 stock splits, with the recent split occurring on Jun 12, 2019.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
BIOCON Chart
Similar
Biocon Ltd. (BIOCON) FAQ
What is the stock price today?
The current price is ₹392.05.
On which exchange is it traded?
Biocon Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is BIOCON.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2%.
What is its market cap?
As of today, the market cap is 397.02B.
When is the next earnings date?
The next earnings report will release on Jan 28, 2026.
Has Biocon Ltd. ever had a stock split?
Biocon Ltd. had 1 splits and the recent split was on Jun 12, 2019.
Biocon Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Siddharth Mittal BCom, CA, CPA CEO | XNSE Exchange | INE376G01013 ISIN |
| India Country | 16,315 Employees | 4 Jul 2025 Last Dividend | 12 Jun 2019 Last Split | - IPO Date |
Overview
Biocon Limited, along with its subsidiaries, marks a prominent presence in the biotechnology industry by manufacturing and selling biotechnology products and providing research services. The company enjoys a significant market footprint not only in India but also extends its reach to Brazil, Singapore, and several other international landscapes. Established in 1978 and headquartered in Bengaluru, India, Biocon Limited operates across four key segments: Generics, Novel Biologics, Biosimilars, and Research Services. This diversified portfolio underscores the company's commitment to innovation, quality, and meeting the expansive needs of the healthcare industry globally.
Products and Services
Biocon Limited offers a comprehensive range of products and services, including:
- Generics: This includes the production and sale of generic formulations and API (Active Pharmaceutical Ingredients) products. The range comprises medications for various health conditions such as anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology among others.
- Novel Biologics: It focuses on the development and commercialization of new molecular entities. Key offerings include a molecule for treating head and neck cancer. The segment showcases Biocon's dedication to advancing therapy through innovation.
- Novel Pipeline Products: These are investigational products under development targeting diseases like psoriasis. This segment emphasizes the company's commitment to expanding its portfolio and addressing unmet medical needs.
- Biosimilars: Biocon has made significant strides in the field of biosimilars, providing alternatives for insulins, trastuzumab, pegfilgrastim, and bevacizumab. Biosimilars play a crucial role in making critical treatments more accessible and affordable.
- Research Services: Offering a range of integrated discovery, development, and manufacturing services, Biocon caters to an array of industries including pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. This diversification indicates the company’s versatile capabilities and expertise in supporting various sectors in their research and product development endeavors.
Contact Information
Address: 20th KM Hosur Road
Phone: 91 80 2808 2808
Website: https://www.biocon.com
2025 © Marketlog. All Rights Reserved.
